Cargando…
Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease
OBJECTIVES: To describe the spectrum of movement disorders and cerebrospinal fluid (CSF) neurotransmitter profiles in paediatric patients with POLG disease. METHODS: We identified children with genetically confirmed POLG disease, in whom CSF neurotransmitter analysis had been undertaken. Clinical da...
Autores principales: | Papandreou, A., Rahman, S., Fratter, C., Ng, J., Meyer, E., Carr, L. J., Champion, M., Clarke, A., Gissen, P., Hemingway, C., Hussain, N., Jayawant, S., King, M. D., Lynch, B. J., Mewasingh, L., Patel, J., Prabhakar, P., Neergheen, V., Pope, S., Heales, S. J. R., Poulton, J., Kurian, Manju A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326959/ https://www.ncbi.nlm.nih.gov/pubmed/30167885 http://dx.doi.org/10.1007/s10545-018-0227-7 |
Ejemplares similares
-
Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders
por: Ng, J., et al.
Publicado: (2014) -
Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations
por: Ashley, Neil, et al.
Publicado: (2008) -
Prospective study of POLG mutations presenting in children with intractable epilepsy: Prevalence and clinical features
por: Uusimaa, Johanna, et al.
Publicado: (2013) -
Understanding the Epilepsy in POLG Related Disease
por: Hikmat, Omar, et al.
Publicado: (2017) -
Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations
por: Visser, Nora A., et al.
Publicado: (2010)